The Shares will commence trading today on the TSX Venture Exchange under the symbol “AEX”
The Offering was made through Paradigm Capital Inc., acting as lead agent, and Canaccord Genuity Corp. (collectively, the “Agents”).
The final prospectus dated June 29, 2017 (the “Final Prospectus”) provides that subsequent closings of the Offering, up to a maximum total issuance of 20,000,000 Shares, may occur at any time on or before September 28, 2017. In addition, Alopex has granted the Agents an over-allotment option (the “Over-Allotment Option”), exercisable in whole or in part for a period of 30 days following the final closing of the Offering, to purchase up to an additional 15% of the aggregate number of Shares issued pursuant to the Offering at the Offering Price to cover over-allotments, if any, and for market stabilization purposes.
Eldur Olafsson, the CEO of Alopex, stated “I am very pleased to announce the successful completion of our IPO on the TSXV and I would like to take this opportunity to thank our existing shareholders for their continuing support and to welcome our new shareholders; this is an exciting and critical phase in the development of our business.” He further remarked that “the management team…